Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Intern Med ; 63(5): 639-647, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-37438139

ABSTRACT

Objective We assessed the factors associated with overlap between functional dyspepsia (FD) and nonerosive reflux disease (NERD) in endoscopy-based Helicobacter pylori-uninfected Japanese health checkup participants. Methods We utilized baseline data from 3,085 individuals who underwent upper endoscopy for health screening in a prospective, multicenter cohort study. The participants were asked to complete a questionnaire detailing their upper abdominal symptoms and lifestyle. Anxiety was assessed using the State-Trait Anxiety Inventory (STAI) score. FD, postprandial distress syndrome (PDS), and epigastric pain syndrome (EPS) were defined according to the Rome III criteria. NERD was defined as heartburn or regurgitation ≥1 day/week without erosive esophagitis. Results Of the 3,085 participants, 73 (2.4%), 97 (3.1%), and 84 (2.7%) had FD alone, NERD alone, and FD-NERD overlap, respectively. Factors associated with FD-NERD-overlap participants compared with participants with neither FD nor NERD were women [odds ratio (OR): 2.08, 95% confidence interval (CI): 1.24-3.52], body mass index (BMI) <18.5 (OR: 2.87, 95% CI: 1.56-5.07), alcohol consumption ≥20 g/day (OR: 1.85, 95% CI: 1.06-3.15), and a high STAI score (OR: 2.53, 95% CI: 1.62-4.00). Increasing age (OR: 1.06, 95% CI: 1.01-1.11) and EPS symptoms [pure EPS (OR: 3.67, 95% CI: 1.65-8.51) and PDS-EPS overlap (OR: 11.6, 95% CI: 4.09-37.2)] were associated with FD-NERD overlap vs. FD alone. Women (OR: 3.17, 95% CI: 1.47-7.04), BMI <18.5 (OR: 3.03, 95% CI: 1.04-9.90), and acid reflux symptoms ≥2 days a week (OR: 3.57, 95% CI: 1.83-7.14) were associated with FD-NERD overlap vs. NERD alone. Conclusion Understanding the clinical features of overlap between FD and NERD will lead to better management.


Subject(s)
Dyspepsia , Gastroesophageal Reflux , Helicobacter pylori , Humans , Female , Male , Dyspepsia/complications , Cross-Sectional Studies , Prospective Studies , Cohort Studies , Japan/epidemiology , Gastroesophageal Reflux/epidemiology , Gastroesophageal Reflux/complications , Endoscopy, Gastrointestinal
2.
BMC Neurol ; 21(1): 242, 2021 Jun 25.
Article in English | MEDLINE | ID: mdl-34172002

ABSTRACT

BACKGROUND: Levodopa-carbidopa intestinal gel (LCIG) treatment, a unique drug delivery system for patients with advanced Parkinson's disease (PD), is covered by health insurance in Japan since September 2016. Various LCIG procedure/device-associated adverse events (AEs) have been reported; however, reports on their treatment have been limited. This is the first multicenter study to clarify the frequency and timing of device-related AEs. METHODS: Between September 2016 and December 2018, 104 patients introduced to the LCIG treatment for advanced PD in 11 hospitals were included. The patients' characteristics, AEs incidence, AEs time, and tube exchange time were investigated. RESULTS: The median follow-up period was 21.5 months. Minor AE cases were 29.4%, whereas major AE cases were 43.1%. Majority of major AEs (n = 55, 94.8%) were managed with endoscopic treatment, such as tube exchange. Few severe AEs required surgical treatment (n =3, 5.2%). The mean (range) exposure to percutaneous endoscopic gastrojejunostomy (PEG-J) was 14.7 (0-33) months. One year after the LCIG treatment introduction, 55 patients (54.0%) retained the original PEG-J tube. The mean PEG-J tube exchange time was 10.8 ± 7.0 months in all patients, 11.6 ± 4.7 and 10.5 ± 7.7 months in patients with scheduled exchange and who underwent exchange due to AEs, respectively. CONCLUSIONS: Some device-related AEs occurred during the LCIG treatment; however, only few were serious, most of which could be treated with simple procedures or tube replacement with endoscopy. Therefore, the LCIG treatment is feasible and safe and is a unique treatment option for PD, requiring endoscopists' understanding and cooperation.


Subject(s)
Antiparkinson Agents , Carbidopa , Gastric Bypass , Gels , Levodopa , Parkinson Disease/drug therapy , Antiparkinson Agents/administration & dosage , Antiparkinson Agents/adverse effects , Antiparkinson Agents/therapeutic use , Carbidopa/administration & dosage , Carbidopa/adverse effects , Carbidopa/therapeutic use , Drug Combinations , Gastric Bypass/adverse effects , Gastric Bypass/methods , Gels/administration & dosage , Gels/adverse effects , Gels/therapeutic use , Humans , Levodopa/administration & dosage , Levodopa/adverse effects , Levodopa/therapeutic use , Retrospective Studies
3.
Nihon Shokakibyo Gakkai Zasshi ; 117(11): 992-1000, 2020.
Article in Japanese | MEDLINE | ID: mdl-33177262

ABSTRACT

A 20-year-old woman with ulcerative colitis flare was admitted to Fukui Red Cross Hospital. During treatment with granulocyte and monocyte apheresis (GMA), the patient complained of chest discomfort and was diagnosed with pulmonary thromboembolism with central intravenous catheter thrombosis. Apixaban, a direct oral anticoagulant (DOAC), was used as monotherapy for anticoagulation, and thromboembolism was resolved without complication. Among extraintestinal complications in patients with ulcerative colitis, pulmonary thromboembolism can be a life-threatening condition and requires prompt anticoagulant therapy. Although the effectiveness of conventional pharmacological anticoagulation using warfarin and heparin has been reported, the efficacy of DOAC monotherapy remains controversial. DOAC monotherapy may be considered and innovative therapeutic strategy for a thromboembolic condition in patients with ulcerative colitis.


Subject(s)
Colitis, Ulcerative , Pulmonary Embolism , Thrombosis , Anticoagulants/therapeutic use , Colitis, Ulcerative/complications , Colitis, Ulcerative/drug therapy , Female , Humans , Pulmonary Embolism/drug therapy , Pulmonary Embolism/etiology , Pyrazoles , Pyridones , Young Adult
4.
JGH Open ; 4(5): 937-944, 2020 Oct.
Article in English | MEDLINE | ID: mdl-33102767

ABSTRACT

BACKGROUND AND AIM: Upper gastrointestinal symptoms (UGSs), including reflux and dyspeptic symptoms (postprandial distress syndrome [PDS] and epigastric pain syndrome [EPS]), affect health-related quality of life. However, the influence of sex on the relationship between body mass index (BMI) and UGSs remains controversial. This study investigates the influence of sex on this association in healthy subjects. METHODS AND RESULTS: We utilized the database of a prospective, multicenter, cohort study of 7112 subjects who underwent upper endoscopy for health screening. A multivariable logistic regression analysis was conducted to assess the association between BMI and UGSs stratified by sex, adjusting for clinical features. The influence of sex on the association between the overlapping of UGSs and BMI in symptomatic subjects was also investigated. Reflux symptoms were significantly associated with high BMI (multivariable odds ratio [OR] 1.36; 95% confidence interval [CI] 1.10-1.67, P = 0.004). PDS symptoms were significantly associated with low BMI (OR 2.37; 95% CI 1.70-3.25; P < 0.0001), but EPS symptoms were not associated with BMI. The association between reflux symptoms and higher BMI was limited to men (men: OR 1.40; 95% CI 1.10-1.77; P = 0.005, women: P = 0.40). sex did not influence the association between the presence of PDS symptoms and lower BMI. The percentage of overlapping of all three symptoms (reflux, PDS, and EPS) was higher in women than in men (19.9% [58/292] vs 10.5% [49/468], P = 0.0002). CONCLUSIONS: The influence of BMI on the presence of UGSs was significantly different according to sex in this large-scale cohort.

5.
PLoS One ; 13(5): e0196848, 2018.
Article in English | MEDLINE | ID: mdl-29723303

ABSTRACT

BACKGROUND: We aimed to clarify the factors associated with the presentation of erosive esophagitis (EE) symptoms in subjects undergoing health checkups. METHODS: We utilized baseline data from 7,552 subjects who underwent upper endoscopy for health screening in a prospective, multicenter cohort study. The subjects were asked to complete a questionnaire detailing their upper abdominal symptoms and lifestyle. Based on the heartburn and/or acid regurgitation frequency, the EE subjects were stratified into the following three groups: (1) at least one day a week (symptomatic EE [sEE]), (2) less than one day a week (mild symptomatic EE [msEE]), and (3) never (asymptomatic EE [aEE]). Postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS) were defined according to the Rome III criteria. RESULTS: Of the 1,262 (16.7%) subjects (male 83.8%, mean age 52.6 years) with EE, the proportions of sEE, msEE and aEE were 15.0%, 37.2% and 47.9%, respectively. The sEE group showed significant associations with overlapping EPS (OR: 58.4, 95% CI: 25.2-160.0), overlapping PDS (OR: 9.96, 95% CI: 3.91-26.8), severe hiatal hernia (OR: 2.43, 95% CI: 1.43-4.05), experiencing high levels of stress (OR: 2.20, 95% CI: 1.43-3.40), atrophic gastritis (OR: 1.57, 95% CI: 1.03-2.36) and Los Angeles (LA) grade B or worse (OR: 1.72, 95% CI: 1.12-2.60) in the multivariate analysis. CONCLUSIONS: Approximately one-sixth of EE subjects were symptomatic. A multifactorial etiology, including factors unrelated to gastric acid secretion, was associated with the symptom presentation of EE subjects.


Subject(s)
Esophagitis, Peptic/diagnosis , Adult , Alcohol Drinking/epidemiology , Anxiety/epidemiology , Asymptomatic Diseases , Comorbidity , Depression/epidemiology , Esophagitis, Peptic/epidemiology , Esophagoscopy , Female , Gastritis, Atrophic/epidemiology , Gastroesophageal Reflux/complications , Gastroesophageal Reflux/epidemiology , Hernia, Hiatal/complications , Hernia, Hiatal/epidemiology , Humans , Japan/epidemiology , Laryngopharyngeal Reflux/complications , Laryngopharyngeal Reflux/epidemiology , Life Style , Male , Middle Aged , Obesity/epidemiology , Pharmaceutical Preparations , Postprandial Period , Prospective Studies , Sleep Initiation and Maintenance Disorders/epidemiology , Smoking/epidemiology , Surveys and Questionnaires , Symptom Assessment
6.
PLoS One ; 13(2): e0192951, 2018.
Article in English | MEDLINE | ID: mdl-29447244

ABSTRACT

BACKGROUND: The association of alcohol intake with the incidence of Barrett's esophagus (BE) has been inconsistent. Although hiatal hernia and male sex are well-known risk factors of BE, its effect on the association of alcohol intake with the incidence of BE remains unknown. AIM: To investigate whether the influence of alcohol intake on the occurrence of BE might differ depending on male sex and presence of hiatal hernia. METHODS: We utilized a database of 8031 patients that underwent upper endoscopy for health screening in a prospective, multicenter, cohort study (the Upper Gastro Intestinal Disease study). The incidence of endoscopic columnar-lined esophagus (eCLE; endoscopically diagnosed BE) was the outcome variable. Multivariable logistic regression analysis was conducted to assess the association between alcohol intake and eCLE stratified by male sex and hiatal hernia, adjusting for clinical features and other potential confounders. RESULTS: Alcohol intake (≥20 g/day) showed a marginally significant association with the incidence of eCLE in participants without hiatal hernia (0 vs. ≥20 g/day; odds ratio [OR], 1.62; 95% confidence interval [CI], 0.92-2.85, P = 0.09) but not in participants with hiatal hernia (0 vs. ≥20/day; OR, 0.99; 95% CI, 0.59-1.65; P = 0.95). Furthermore, alcohol intake (≥20 g/day) was significantly associated with the incidence of eCLE in male participants without hiatal hernia (0 vs. ≥20 g/day; OR, 1.98; 95% CI, 1.04-4.03; P = 0.04) but not in female participants without hiatal hernia (0 vs. ≥20 g/day; OR, 0.47; 95% CI, 0.03-2.37; P = 0.42). CONCLUSIONS: The effect of alcohol intake on the incidence of eCLE might be associated with hiatal hernia status and male sex.


Subject(s)
Alcohol Drinking/epidemiology , Barrett Esophagus/epidemiology , Hernia, Hiatal/epidemiology , Barrett Esophagus/complications , Barrett Esophagus/diagnostic imaging , Esophagoscopy , Female , Hernia, Hiatal/complications , Hernia, Hiatal/diagnostic imaging , Humans , Incidence , Logistic Models , Male , Middle Aged , Odds Ratio , Prospective Studies , Risk Factors , Sex Factors
7.
Kobe J Med Sci ; 63(2): E58-E67, 2017 Nov 22.
Article in English | MEDLINE | ID: mdl-29434176

ABSTRACT

Helicobacter pylori, which is involved in the pathogenesis of gastroduodenal disease, produces CagA and VacA as major virulence factors. CagA is classified into East Asian and Western types based on the number and sequences of its Glu-Pro-Ile-Tyr-Ala motifs. The vacA gene has three polymorphic regions: the signal (s), intermediate (i), and middle (m) regions. The lowest gastric cancer mortality rate is seen in Okinawa. On the Japanese mainland (Honshu), most H. pylori produce s1/m1-VacA, which exhibits strong toxicity, and East Asian-type CagA. However, the H. pylori detected in Okinawa produces s1/m2-VacA, which exhibits weak toxicity, or s2/m2-VacA, which is non-toxic, and Western-type CagA. Studies about the i-region of vacA have been performed around the world, but there have been few such studies in Japan. Therefore, the aim of this study was to assess the relationships between the clinical outcomes of H. pylori infections in Okinawa, vacA (especially the i-region genotype), and cagA. H. pylori strains that were collected from patients with gastric cancer or gastric ulcers in Okinawa only produced the i1-type VacA virulence factor. The vacuolating cytotoxin activity of i1-type VacA was stronger than that of i2-type VacA, suggesting that the i-region genotype of vacA is closely associated with vacuolating cytotoxin activity. These results indicate that the i-region genotype of vacA is a useful marker of both H. pylori virulence and the clinical outcomes of H. pylori infections in Okinawa, Japan.


Subject(s)
Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Helicobacter Infections/microbiology , Helicobacter pylori/genetics , Helicobacter pylori/pathogenicity , Gastritis/microbiology , Genes, Bacterial , Genotype , Humans , Japan , Peptic Ulcer/microbiology , Prognosis , Stomach Neoplasms/microbiology , Virulence Factors/genetics
8.
J Gastroenterol ; 47(11): 1186-97, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22526273

ABSTRACT

BACKGROUND: Patients using low-dose aspirin (LDA) have an increased risk of gastroduodenal mucosal lesions and upper gastrointestinal symptoms. We aimed to clarify the efficacy of rabeprazole for preventing peptic ulcer, esophagitis, and gastrointestinal symptoms associated with LDA. METHODS: Patients with a history of peptic ulcers who were receiving LDA for cardiovascular or cerebrovascular disease were randomly assigned to receive rabeprazole at 10 mg daily, rabeprazole at 20 mg daily, or gefarnate (a cytoprotective anti-ulcer agent) at 50 mg twice daily. The primary endpoint was the development of gastric and/or duodenal ulcer at 12 weeks. The modified Lanza score (MLS) and gastrointestinal symptoms were evaluated at baseline and at 12 weeks. RESULTS: The full analysis set comprised 261 patients (rabeprazole 10 mg: n = 87, rabeprazole 20 mg: n = 89, gefarnate 100 mg: n = 85). The cumulative incidences of gastroduodenal ulcers at 12 weeks in the 10 mg rabeprazole group, 20 mg rabeprazole group, and gefarnate group were 7.4, 3.7, and 26.7 %, respectively (rabeprazole group 5.5 % vs. gefarnate group 26.7 %, hazard ratio [HR] 0.179; 95 % confidence interval [CI] 0.082-0.394; p < 0.0001). The proportions of patients with an MLS of ≥1 and erosive esophagitis were significantly lower in the rabeprazole group than in the gefarnate group at 12 weeks (gastric lesions 33.5 vs. 62.4 %, p < 0.0001; duodenal lesions 5.7 vs. 24.7 %, p < 0.0001; erosive esophagitis 5.8 vs. 19.4 %, p < 0.0001). Rabeprazole was significantly more effective than gefarnate for the resolution and prevention of gastrointestinal symptoms (resolution 53.6 vs. 25.0 %, p = 0.017; occurrence 9.2 vs. 28.3 %, p = 0.0026). CONCLUSIONS: Rabeprazole is more effective than gefarnate for reducing the risk of recurrence of peptic ulcer, esophagitis, and gastrointestinal symptoms in LDA users.


Subject(s)
2-Pyridinylmethylsulfinylbenzimidazoles/therapeutic use , Anti-Ulcer Agents/therapeutic use , Aspirin/adverse effects , Peptic Ulcer/prevention & control , Aged , Aspirin/therapeutic use , Cardiovascular Diseases/drug therapy , Cerebrovascular Disorders/drug therapy , Dose-Response Relationship, Drug , Esophagitis/chemically induced , Esophagitis/prevention & control , Female , Gefarnate/therapeutic use , Humans , Male , Middle Aged , Peptic Ulcer/chemically induced , Platelet Aggregation Inhibitors/adverse effects , Platelet Aggregation Inhibitors/therapeutic use , Prospective Studies , Rabeprazole , Secondary Prevention
9.
FEMS Immunol Med Microbiol ; 60(1): 90-7, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20670275

ABSTRACT

Helicobacter pylori CagA protein is considered a major virulence factor associated with gastric cancer. There are two major types of CagA proteins: the Western and East Asian CagA. The East Asian CagA-positive H. pylori infection is more closely associated with gastric cancer. The prevalence of gastric cancer is quite low in the Philippines, although Philippine populations are considered to originate from an East Asia source. This study investigates the characteristics of the cagA gene and CagA protein in Philippine H. pylori strains and compares them with previously characterized reference strains worldwide. The full-length cagA gene was sequenced from 19 Philippine isolates and phylogenetic relationships between the Philippine and 40 reference strains were analyzed. All Philippine strains examined were cagA positive, and 73.7% (14/19) strains were Western CagA-positive. The phylogenetic tree based on the deduced amino acid sequence of CagA indicated that the Philippine strains were classified into the two major groups of CagA protein: the Western and the East Asian group. These findings suggest that the modern Western influence may have resulted in more Western type H. pylori strains in the Philippines. Therefore, H. pylori-infected Filipinos can be considered to be at a low risk of developing gastric cancer.


Subject(s)
Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Genetic Variation , Helicobacter Infections/microbiology , Helicobacter pylori/genetics , Peptic Ulcer/microbiology , Adult , Aged , Cluster Analysis , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Female , Helicobacter Infections/pathology , Helicobacter pylori/isolation & purification , Humans , Male , Middle Aged , Molecular Sequence Data , Peptic Ulcer/pathology , Philippines , Phylogeny , Sequence Analysis, DNA , Sequence Homology, Amino Acid
10.
Digestion ; 79(4): 235-42, 2009.
Article in English | MEDLINE | ID: mdl-19401613

ABSTRACT

BACKGROUND AND AIM: The relationship between Helicobacter pylori infection and body mass index (BMI) and dyspeptic symptoms is controversial. We investigated the changes in BMI and dyspeptic symptoms after H. pylori eradication among stages of atrophic gastritis classified according to the serum pepsinogen (PG) I/II ratio. METHODS: One hundred and sixty-three H. pylori-positive patients underwent eradication therapy for H. pylori. Serum PG I and II concentrations were measured before treatment, and the PG I/II ratio was classified into three groups: PG I/II ratio <2.0, PG I/II ratio >or=2.0 and <4.0, and PG I/II ratio >or=4.0 were considered to be low, middle, and high, respectively. Their BMI and abdominal symptoms were checked before, 1 and 5 years after treatment, and these changes were investigated among the three groups. RESULTS: The mean BMI changes 1 year after treatment in the low PG I/II ratio group were significantly higher than those in other groups. Most abdominal symptoms in the high PG I/II ratio group were most severe before eradication but improved significantly after eradication. CONCLUSIONS: The effects of H. pylori eradication on BMI and dyspeptic symptoms may be different according to the serum PG I/II ratio before eradication.


Subject(s)
Dyspepsia/drug therapy , Gastritis, Atrophic/drug therapy , Helicobacter Infections/drug therapy , Helicobacter pylori , Adult , Body Mass Index , Dyspepsia/blood , Dyspepsia/microbiology , Female , Gastritis, Atrophic/blood , Gastritis, Atrophic/microbiology , Helicobacter Infections/blood , Helicobacter Infections/complications , Humans , Male , Middle Aged , Pepsinogens/blood
12.
J Gastroenterol ; 41(7): 668-73, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16933004

ABSTRACT

BACKGROUND: Helicobacter pylori CagA protein is considered to be one of the virulence factors associated with gastric cancer. CagA is injected into gastric epithelial cells, undergoes tyrosine phosphorylation, and binds to Src homology 2 domain-containing protein-tyrosine phosphatase (SHP-2). Two major subtypes of CagA have been observed in the SHP-2-binding site, the Western and East Asian types. The East Asian-type CagA binds to SHP-2 more strongly than the Western-type CagA. The diversity of CagA, which collectively determines the binding affinity of CagA to SHP-2, may be an important variable in determining the clinical outcome of infection by different H. pylori strains. METHODS: We investigated the relationship between the diversity of CagA and clinical outcome in Okinawa, Japan. A total 24 strains, 13 gastric cancer strains and 11 duodenal ulcer strains, were studied. We sequenced full-length cagA genes and analyzed the phylogenetic relationships between Okinawa isolates and previously characterized Western H. pylori strains. RESULTS: All isolates examined were cagA positive. The prevalence of East Asian CagA-positive strains was significantly higher in patients with gastric cancer (84.6%) than in patients with duodenal ulcer (27.3%) (chi-squared = 8.06, P = 0.011). The phylogenetic analysis showed that all gastric cancer strains with East Asian-type CagA were in the East Asian cluster, and that most duodenal ulcer strains were in the Western cluster. CONCLUSIONS: The origins of H. pylori isolates are different between gastric cancer strains and duodenal ulcer strains, and East Asian CagA-positive H. pylori infection is associated with gastric cancer. The strain diversity observed in Okinawa may affect the difference in the prevalence of disease associated with H. pylori infection in Japan.


Subject(s)
Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Duodenal Ulcer/microbiology , Genetic Variation , Helicobacter Infections/microbiology , Helicobacter pylori/genetics , Stomach Neoplasms/microbiology , Adult , Aged , Aged, 80 and over , Antigens, Bacterial/classification , Bacterial Proteins/classification , Duodenal Ulcer/epidemiology , Female , Helicobacter Infections/epidemiology , Helicobacter pylori/classification , Helicobacter pylori/isolation & purification , Helicobacter pylori/pathogenicity , Humans , Japan/epidemiology , Male , Middle Aged , Phylogeny , Prevalence , Sequence Analysis, DNA , Stomach Neoplasms/epidemiology
13.
J Gastroenterol ; 40(9): 873-7, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16211343

ABSTRACT

BACKGROUND: Interleukin-1beta (IL-1beta) gene polymorphisms are related to hypochlorhydria and increase the risk of gastric cancer in the presence of Helicobacter pylori infection. However, little information is available about the genetic risk factors of reflux esophagitis. In this study we investigated its association with the IL-1beta polymorphisms. METHODS: We examined 48 patients with reflux esophagitis and 96 control subjects, 89 with gastric cancer. IL-1beta-511C/T genotyping was performed by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. RESULTS: The frequency of IL-1beta-511T alleles was significantly higher in reflux esophagitis patients (57.3%) than in controls (41.1%) (P = 0.0215, chi(2) = 5.289). The frequency of IL-1beta-511T/T genotypes was also significantly higher in reflux esophagitis patients (31.3%) than in controls (15.6%). The odds ratio and the 95% confidence interval were 4.000 and 1.393-11.486, respectively. The frequency of IL-1beta-511T/T genotypes was significantly higher in reflux esophagitis patients (31.3%) than in gastric cancer patients (21.4%). The odds ratio and the 95% confidence interval were 2.961 and 1.054-8.316, respectively. CONCLUSIONS: IL-1beta-511T was associated with reflux esophagitis having hyperacidity. Differences of genetic background regarding gastric acid secretion may exist between Japanese and Caucasians.


Subject(s)
DNA/genetics , Esophagitis, Peptic/genetics , Interleukin-1/genetics , Polymorphism, Restriction Fragment Length , Alleles , Electrophoresis, Polyacrylamide Gel , Esophagitis, Peptic/blood , Esophagitis, Peptic/epidemiology , Female , Gene Frequency , Genetic Predisposition to Disease , Genotype , Humans , Incidence , Interleukin-1/blood , Japan/epidemiology , Male , Middle Aged , Polymerase Chain Reaction
14.
J Clin Microbiol ; 43(8): 3906-16, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16081930

ABSTRACT

Colonization of the stomach mucosa by Helicobacter pylori is a major cause of acute and chronic gastric pathologies in humans. Several H. pylori virulence genes that may play a role in its pathogenicity have been identified. The most important determinants are vacA and cagA in the cag pathogenicity island (cagPAI) genes. In the present study, to consider the association of molecular genetics between vacA and the cagPAI regarding clinical outcome, we selected H. pylori strains with various genotypes of vacA in Japan and sequenced full-length vacA, cagA, and cagE genes. Sequencing of vacA and cagA genes revealed variable size, whereas the cagE gene was well conserved among strains. Each of the phylogenetic trees based on the deduced amino acid sequences of VacA, CagA, and CagE indicated that all three proteins were divided into two major groups, a Western group and an East Asian group, and the distributions of isolates exhibited similar patterns among the three proteins. The strains with s2 and s1a/m1a vacA genotypes and the Western-type 3' region cagA genotype were classified into the Western group, and the strains with the s1c/m1b vacA genotype and the East Asian-type 3' cagA genotype were included in the East Asian group. In addition, the prevalence of infection with the Western group strain was significantly higher in patients with peptic ulcer (90.0%, 9/10) than in patients with chronic gastritis (22.7%, 5/22) (chi2 = 12.64, P = 0.00057). These data suggest that the molecular genetics of vacA and cagPAI are associated and that the Western group with vacA and cagPAI genes is associated with peptic ulcer disease.


Subject(s)
Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Helicobacter pylori/genetics , Peptic Ulcer/microbiology , Amino Acid Sequence , Base Sequence , Genetic Variation , Humans , Molecular Sequence Data , Phylogeny
15.
FEMS Immunol Med Microbiol ; 44(3): 261-8, 2005 Jun 01.
Article in English | MEDLINE | ID: mdl-15907447

ABSTRACT

The CagA protein is one of the virulence factors of Helicobacter pylori, and two major subtypes of CagA have been observed, the Western and East Asian type. CagA is injected from the bacteria into gastric epithelial cells, undergoes tyrosine phosphorylation, and binds to Src homology 2 domain-containing protein-tyrosine phosphatase SHP-2. The East Asian type CagA binds to SHP-2 more strongly than the Western type CagA. Here, we tried to distinguish the CagA type by highly sensitive real-time PCR with the objective of establishing a system to detect H. pylori and CagA subtypes from gastric biopsies. We designed primers and probe sets for Western or East Asian-cagA at Western-specific or East Asian-specific sequence regions, respectively, and H. pylori 16S rRNA. We could detect the H. pylori 16S rRNA gene, Western and East Asian-cagA gene from DNA of gastric biopsies. The sensitivity and specificity for H. pylori infection was 100% in this system. In Thai patients, 87.8% (36/41) were cagA-positive; 26.8% (11/41) were Western-cagA positive and 53.7% (22/41) were East Asian-cagA positive, while 7.3% (3/41) reacted with both types of cagA. These results suggest that this real-time PCR system provides a highly sensitive assessment of CagA type as a new diagnostic tool for the pathogenicity of H. pylori infection.


Subject(s)
Antigens, Bacterial/isolation & purification , Bacterial Proteins/isolation & purification , Gastric Mucosa/microbiology , Genes, Bacterial , Helicobacter Infections/diagnosis , Helicobacter pylori/isolation & purification , Polymerase Chain Reaction/methods , Adult , Aged , Amino Acid Sequence , Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Base Sequence , Biopsy , Female , Helicobacter Infections/microbiology , Helicobacter pylori/genetics , Humans , Male , Middle Aged , Molecular Sequence Data , Polymorphism, Genetic , RNA, Bacterial/analysis , RNA, Ribosomal, 16S/analysis , Sensitivity and Specificity , Thailand
16.
World J Gastroenterol ; 11(10): 1535-9, 2005 Mar 14.
Article in English | MEDLINE | ID: mdl-15770733

ABSTRACT

AIM: To examine the etiology and pathophysiology in human ischemic colitis from the viewpoint of ischemic factors such as hypoxia-inducible factor 1 alpha (HIF-1 alpha and vascular endothelial growth factor (VEGF). METHODS: Thirteen patients with ischemic colitis and 21 normal controls underwent colonoscopy. The follow-up colonoscopy was performed in 8 patients at 7 to 10 d after the occurrence of ischemic colitis. Biopsy samples were subjected to real-time RT-PCR and immunohistochemistry to detect the expression of HIF-1 alpha and VEGF. RESULTS: HIF-1 alpha and VEGF expression were found in the normal colon tissues by RT-PCR and immunohistochemistry. HIF-1 alpha and VEGF were overexpressed in the lesions of ischemic colitis. Overexpressed HIF-1 alpha and VEGF RNA quickly decreased to the normal level in the scar regions at 7 to 10 d after the occurrence of ischemic colitis. CONCLUSION: Constant expression of HIF-1 alpha and VEGF in normal human colon tissue suggested that HIF-1 alpha and VEGF play an important role in maintaining tissue integrity. We confirmed the ischemic crisis in ischemic colitis at the molecular level, demonstrating overexpression of HIF-1 alpha and VEGF in ischemic lesions. These ischemic factors may play an important role in the pathophysiology of ischemic colitis.


Subject(s)
Colitis, Ischemic/metabolism , DNA-Binding Proteins/metabolism , Nuclear Proteins/metabolism , Transcription Factors/metabolism , Vascular Endothelial Growth Factor A/metabolism , Case-Control Studies , DNA-Binding Proteins/genetics , Female , Humans , Hypoxia-Inducible Factor 1 , Hypoxia-Inducible Factor 1, alpha Subunit , Immunohistochemistry , Male , Middle Aged , Nuclear Proteins/genetics , RNA, Messenger/metabolism , Transcription Factors/genetics , Vascular Endothelial Growth Factor A/genetics
17.
J Clin Microbiol ; 42(6): 2508-17, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15184428

ABSTRACT

The severity of Helicobacter pylori-related disease is correlated with the presence of a cag pathogenicity island (PAI). Genetic diversity within the cag PAI may have a modifying effect on the pathogenic potential of the infecting strain. We analyzed the complete cag PAI sequences of 11 representative Japanese strains according to their vacA genotypes and clinical effects and examined the relationship between the diversity of the cag PAI and clinical features. The cag PAI genes were divided into two major groups, a Western and a Japanese group, by phylogenetic analysis based on the entire cag PAI sequences. The predominant Japanese strains formed a Japanese cluster which was different from the cluster formed by Western strains. The diversity of the cag PAI was associated with the vacA and cagA genotypes. All strains with the s1c vacA genotype were in the Japanese cluster. In addition, all strains with the East Asian-type cagA genotype were also in the Japanese cluster. Patients infected with the Japanese-cluster strain had high-grade gastric mucosal atrophy. These results suggest that a distinct diversity of the cag PAI of H. pylori is present among Japanese strains and that this diversity may be involved in the development of atrophic gastritis and may increase the risk for gastric cancer.


Subject(s)
Helicobacter pylori/genetics , Helicobacter pylori/pathogenicity , Antigens, Bacterial/metabolism , Bacterial Proteins/metabolism , Helicobacter pylori/classification , Humans , Intracellular Signaling Peptides and Proteins , Phosphorylation , Phylogeny , Protein Transport , Protein Tyrosine Phosphatase, Non-Receptor Type 11 , Protein Tyrosine Phosphatases/metabolism
19.
J Infect Dis ; 189(5): 820-7, 2004 Mar 01.
Article in English | MEDLINE | ID: mdl-14976598

ABSTRACT

We investigated the relationship between the diversity of Helicobacter pylori CagA protein and clinical outcome. The cagA gene was sequenced in 115 clinical isolates. The binding affinity of CagA to Src homology 2 domain-containing tyrosine phosphatase (SHP-2) was examined by in vitro infection. Two major CagA subtypes were observed--the East Asian and the Western type. The grades of inflammation, activity of gastritis, and atrophy were significantly higher in patients with gastritis infected with the East Asian CagA-positive strain than in patients with gastritis infected with cagA-negative or Western CagA-positive strains. All strains isolated from patients with gastric cancer were East Asian CagA positive. East Asian CagA exhibited stronger SHP-2-binding activity than did Western CagA. These findings suggest that infection with East Asian CagA-positive H. pylori is associated with atrophic gastritis and gastric cancer and that persistent active inflammation induced by the East Asian CagA-positive strain may play a role in the pathogenesis of disease.


Subject(s)
Antigens, Bacterial/metabolism , Bacterial Proteins/metabolism , Gastric Mucosa/pathology , Helicobacter pylori/genetics , Protein Tyrosine Phosphatases/metabolism , Stomach Neoplasms/pathology , Stomach/pathology , Amino Acid Sequence , Base Sequence , Binding Sites , Conserved Sequence , DNA Primers , Gastritis/microbiology , Gastritis/pathology , Genetic Variation , Helicobacter pylori/isolation & purification , Humans , Molecular Sequence Data , Sequence Alignment , Stomach Neoplasms/microbiology , src Homology Domains
20.
Intern Med ; 43(12): 1205-9, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15645661

ABSTRACT

Primary varicella infection in immunocompetent adults is very rare, but it has a high mortality rate because of serious complications. We describe a case of varicella infection in a previously healthy young adult complicated with acute respiratory distress syndrome (ARDS), rhabdomyolysis, acute hepatitis and disseminated intravascular coagulation (DIC). Acyclovir was administered for varicella infection and the ARDS was successfully treated with steroidpulse therapy, hemofiltration and a mechanical respiratory support with a positive end-expiratory pressure. Early administration of antiviral agents and extensive management were thought to be necessary for such patients with severe complications.


Subject(s)
Chickenpox/complications , Disseminated Intravascular Coagulation/complications , Pneumonia, Viral/complications , Respiratory Distress Syndrome/complications , Adult , Chickenpox/diagnosis , Humans , Immunocompetence , Male , Pneumonia, Viral/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...